ClinicalTrialStartPulse / compare
Janssen Research & Development, LLC vs Otsuka Pharmaceutical Development & Commercialization, Inc.: ClinicalTrialStartPulse comparison
Janssen Research & Development, LLC's enrollment of 539 is 1.0x Otsuka Pharmaceutical Development & Commercialization, Inc.'s 538 (90th percentile). Janssen Research & Development, LLC is dated 2026-11-03; Otsuka Pharmaceutical Development & Commercialization, Inc. 2026-10-05.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Both records plus every comparable US record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does Janssen Research & Development, LLC compare to Otsuka Pharmaceutical Development & Commercialization, Inc.?
| Field | Janssen Research & Development, LLC | Otsuka Pharmaceutical Development & Commercialization, Inc. |
|---|---|---|
| Sponsor | Janssen Research & Development, LLC | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Sponsor type | Industry (pharma, biotech, medtech) | Industry (pharma, biotech, medtech) |
| Study | A Long-term Extension Study of PCI-32765 (Ibrutinib) | A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia |
| NCT ID | NCT01804686 | NCT06894212 |
| Phase | Phase 3 | Phase 3 |
| Status | active not recruiting | active not recruiting |
| Conditions | Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Mantle Cell Lymphoma; Follicular Lymphoma; Diffuse Large B-cell Lymphoma; Waldenstrom Macroglobulinemia | Schizophrenia |
| Intervention types | drug | drug, other |
| Target enrollment | 539 | 538 |
| Site countries | United States, Argentina, Australia, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Germany, Greece | United States, Japan |
| Posted | 2013-03-05 | 2025-03-25 |
| Planned start | 2013-09-09 | 2025-02-28 |
| Event | Enrollment closed (active, not recruiting) | Enrollment closed (active, not recruiting) |
| Event date | 2026-11-03 | 2026-10-05 |
| Last update posted | 2026-11-03 | 2026-10-05 |
| enrollment percentile | 90th | 90th |
| Score | 100/100 | 75/100 |
| Peer rank and all 500 US records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: Janssen Research & Development, LLC · Otsuka Pharmaceutical Development & Commercialization, Inc.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.